Pharmabiz

TytoCare receives FDA De Novo classification for the first model of Tyto Insights for ENT Suite

TytoCare receives FDA De Novo classification for the first model of Tyto Insights for ENT Suite: New York Wednesday, April 29, 2026, 13:00 Hrs [IST] TytoCare, a virtual care compa ...
Pharmabiz

SRM Medical College Hospital and Research Centre Hosts “Illuminova ’26”: A futuristic UG research expo advancing healthcare with AI

SRM Medical College Hospital and Research Centre Hosts “Illuminova ’26”: A futuristic UG research expo advancing healthcare with AI: Our Bureau, Bengaluru Wednesday, April 2 ...
Pharmabiz

ISMOCD with AMC and Envu India helps unite India’s public health leadership to advance urban vector-borne disease control

ISMOCD with AMC and Envu India helps unite India’s public health leadership to advance urban vector-borne disease control: Our Bureau, Bengaluru Wednesday, April 29, 2026, 12:15 ...
Pharmabiz

AbbVie seeks US FDA approval for Skyrizi subcutaneous induction for adults with moderately to severely active Crohn's disease

AbbVie seeks US FDA approval for Skyrizi subcutaneous induction for adults with moderately to severely active Crohn's disease: North Chicago, Illinois Wednesday, April 29, 2026, 1 ...
Pharmabiz

Athulya Senior Care inks MoU with SingHealth to advance care, training and research collaboration

Athulya Senior Care inks MoU with SingHealth to advance care, training and research collaboration: Our Bureau, Bengaluru Wednesday, April 29, 2026, 11:45 Hrs [IST] Athulya Senior ...
Pharmabiz

Thermo Fisher Scientific inks agreement to sell its microbiology business to Astorg for approximately $1.075 billion

Thermo Fisher Scientific inks agreement to sell its microbiology business to Astorg for approximately $1.075 billion: Waltham, Massachusetts Wednesday, April 29, 2026, 11:00 Hrs [ ...
Pharmabiz

Assocham Pharma Summit & Excellence Awards 2026

Against this backdrop, the Assocham Pharma Summit & Excellence Awards 2026 will serve as a premier platform for dialogue, collaboration, and recognition. Bringing together policymakers, regulators, ...
Pharmabiz

Dr Reddy's Labs gets Health Canada approval for generic semaglutide injection

Dr Reddy's Labs gets Health Canada approval for generic semaglutide injection: Our Bureau, Bengaluru Wednesday, April 29, 2026, 11:35 Hrs [IST] Dr Reddy’s Laboratories has recei ...
Pharmabiz

Boston Cell Standards enters into final phase of US FDA’s MDDT programme to qualify first-in-industry to standardize cancer diagnostic assays

Boston Cell Standards enters into final phase of US FDA’s MDDT programme to qualify first-in-industry to standardize cancer diagnostic assays: Boston Wednesday, April 29, 2026, ...
Pharmabiz

GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA PRIME designations to treat MASH

GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA PRIME designations to treat MASH: London, UK Wednesday, April 29, 2026, 09:00 Hrs ...
Pharmabiz

DCC recommends sub-committee to deliberate on proposals related to NAP on AMR 2.0

DCC recommends sub-committee to deliberate on proposals related to NAP on AMR 2.0: Gireesh Babu, New Delhi Wednesday, April 29, 2026, 08:00 Hrs [IST] The Drugs Consultative Commit ...
Opinion
PharmabizOpinion

SHED THE CAVALIER ATTITUDE

The DoP should now shed its cavalier attitude towards such a game-changing scheme and should leave no stones unturned to ensure that the funds allocated for the scheme is fully utilised.